User Settings
Other

Asthma & COPD - SMi's sixth annual conference.

Saloni Shah-2010-06-01-PubMed
1

TL;DRAbstract

SMi's sixth annual conference on Asthma & COPD, held in London, included topics covering new therapeutic developments in the field of asthma and COPD. This conference report highlights selected presentations on understanding these diseases; bronchodilators and corticosteroids, both of which remain a mainstay in asthma therapy; new developments in COPD therapy; PI3K inhibitors as a new treatment approach for asthma and COPD; and oligonucleotides, particularly DNAzyme therapy for asthma.

Chat with Paper

AI Agents for this Paper

SMi's sixth annual conference on Asthma & COPD, held in London, included topics covering new therapeutic developments in the field of asthma and COPD. This conference report highlights selected presentations on understanding these diseases; bronchodilators and corticosteroids, both of which remain a mainstay in asthma therapy; new developments in COPD therapy; PI3K inhibitors as a new treatment approach for asthma and COPD; and oligonucleotides, particularly DNAzyme therapy for asthma.

Keywords

AsthmaCOPDMedicineInhaled corticosteroidsIntensive care medicinePulmonary diseasePhysical therapyInternal medicine

Chat

Click to start Chat